PhD, Health Policy
Harvard University
SM, Population and International Health
Harvard University
AB, History
Dartmouth College
Publications
Limited user fees for adult HIV diagnosis and routine laboratory monitoring in the global IeDEA consortium: analysis in 42 countries.
December 2025 | medRxiv
Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: Informing achievement of global targets across sub-populations in Rwanda.
May 2025 | PLoS One
Sustaining Rwanda’s HIV response after elimination of PEPFAR funding: a modeling analysis.
April 2025 | medRxiv
The economic costs and cost-effectiveness of HIV self-testing among truck drivers in Kenya.
March 2024 | Health Policy and Planning
Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
July 2019 | Journal of the International AIDS Society
Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: A consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA).
January 2019 | Journal of the International AIDS Society
Mathematical modelling to inform ‘treat all’ implementation in sub-Saharan Africa: A scoping review.
November 2018 | Journal of Virus Eradication
Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections.
March 2018 | PLoS ONE
HIV prevention resources: Time to move toward affordability.
February 2017 | Lancet HIV
Clinical outcomes of HIV care delivery models in the US: A systematic review.
October 2016 | AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV
Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings.
February 2015 | Medical Decision Making
Home HIV testing and counselling: Answers raising questions.
November 2014 | Lancet HIV
Lives saved by expanding HIV treatment availability in resource-limited settings: The example of Haiti.
June 2013 | Journal of Acquired Immune Deficiency Syndromes
Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.
September 2012 | Cost Effectiveness and Resource Allocation
Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: A qualitative assessment.
February 2012 | AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: Modeling clinical outcomes in infants and mothers.
June 2011 | PLoS One
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: A cost-effectiveness analysis of the OCTANE trial.
February 2011 | AIDS
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.
February 2011 | HIV Medicine
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
September 2010 | PLoS One
Assessing the performance of a computer-based policy model of HIV and AIDS.
September 2010 | PLoS One
Test and treat DC: Forecasting the impact of a comprehensive HIV strategy in Washington DC.
August 2010 | Clinical Infectious Diseases
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: Clinical benefits and cost-effectiveness.
July 2010 | Journal of Acquired Immune Deficiency Syndromes
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d’Ivoire appraisal.
October 2009 | PLoS Medicine
When to start antiretroviral therapy in resource-limited settings.
August 2009 | Annals of Internal Medicine
Scaling up antiretroviral therapy in South Africa: The impact of speed on survival.
May 2008 | Journal of Infectious Diseases
Cost-effectiveness of HIV treatment in resource-poor settings–the case of Côte d’Ivoire.
September 2006 | New England Journal of Medicine
Diagnostic tests in HIV management: A review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries.
July 2006 | Bulletin of the World Health Organ
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease.
May 2005 | Journal of Acquired Immune Deficiency Syndromes
Routine human immunodeficiency virus testing: An economic evaluation of current guidelines.
March 2005 | The American Journal of Medicine
Expanded screening for HIV in the United States–an analysis of cost-effectiveness.
February 2005 | New England Journal of Medicine
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
January 2005 | Antiviral Therapy
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.
December 2003 | The American Journal of Medicine
Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.
December 2002 | Antiviral Therapy
Treatment for primary HIV infection: Projecting outcomes of immediate, interrupted, or delayed therapy.
September 2002 | Journal of Acquired Immune Deficiency Syndromes
The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.
August 2002 | Journal of Acquired Immune Deficiency Syndromes
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: Using simulation modeling to inform clinical guidelines.
April 2002 | Archives of Internal Medicine